NCT00005948View on ClinicalTrials.gov

Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2000

Primary Completion Date

October 31, 2001

Study Completion Date

October 31, 2001

Conditions
Leukemia
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

sargramostim

DRUG

busulfan

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

80010

University of Colorado Cancer Center, Denver

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00005948 - Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter